Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease
Takeo Koshida, Tomohito Gohda, Takuya Sugimoto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11456-11456
Open Access | Times Cited: 10

Showing 10 citing articles:

Bibliometric Analysis of the Relationship between Gut Microbiota and Chronic Kidney Disease from 2001–2022
Pengyu Tao, Jinlin Huo, Ling Chen
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 1
Closed Access | Times Cited: 4
Gut Microbiota in Patients Receiving Dialysis: A Review
Xintian Lim, Lijin Ooi, Uzhe Ding, et al.
Pathogens (2024) Vol. 13, Iss. 9, pp. 801-801
Open Access | Times Cited: 3
Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes
Oana C. Iatcu, Sevag Hamamah, Mihai Covașă
Nutrients (2024) Vol. 16, Iss. 20, pp. 3447-3447
Open Access | Times Cited: 3
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN
J. Liu, Min Guo, Xiaobin Yuan, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
Microbiota analysis in individuals with type two diabetes mellitus and end‑stage renal disease: A pilot study
Maria Trandafir, Grațiela Grădișteanu Pîrcălăbioru, Octavian Savu
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 2
Gut–Kidney–Heart: A Novel Trilogy
Mario Caldarelli, Laura Franza, Pierluigi Rio, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3063-3063
Open Access | Times Cited: 6
Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease?
Yuselys García-Martínez, Elena Alexandrova, Valerio Iebba, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The Potential of Naturally Derived Compounds for Treating Chronic Kidney Disease: A Review of Autophagy and Cellular Senescence
Yoong Mond Teh, Siti Aisyah Mualif, Nur Izzati Mohd Noh, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 3-3
Open Access
Association between Dental Scores and Saliva Uremic Toxins
Claire Rigothier, Sylvain Catros, Antoine Bénard, et al.
Toxins (2023) Vol. 15, Iss. 11, pp. 666-666
Open Access | Times Cited: 1
Inappropriate diet and hygiene status affect the progression of diabetic kidney disease by causing dysbiosis
Takeo Koshida, Tomohito Gohda, Naoko Kaga, et al.
Nutrition (2024) Vol. 131, pp. 112633-112633
Closed Access
III. The Roles of Microbiota and Its Metabolites in CKD
Shiori Nakagawa, Yasunori Iwata, Takashi Wada
Nihon Naika Gakkai Zasshi (2024) Vol. 113, Iss. 5, pp. 780-784
Open Access
Page 1

Scroll to top